Cometriq (Cabozantinib)


Medical Evidence cometriq

Generic name : Cabozantinib.

Trade name : Cometriq.

Manufacturer information :

Cometriq is manufactured by Exelixis, Inc.

Cometriq FDA Approval :

Cometriq first approved November 29th, 2012.

Cometriq Dosage form :

20 mg and 80 mg capsules.

Cometriq Indications and Usage :

Medullary Thyroid Cancer

Indicated for treatment of progressive, metastatic medullary thyroid cancer.

Cometriq (Cabozantinib) availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.